Advanced Diabetes care: three levels of prediction, prevention & personalized treatment
- PMID: 20034368
- DOI: 10.2174/157339910790442637
Advanced Diabetes care: three levels of prediction, prevention & personalized treatment
Abstract
Worldwide epidemic scale of Diabetes mellitus (DM) has been underestimated for a long time. Currently every 10 seconds one patient dies of diabetes-related pathologies. Given the high risk and prevalence of secondary complications as well as individual predisposition to target organ injury, DM is one of the best examples for the application of predictive diagnostics aimed at preventive measures and personalized treatment approaches. Generally there are three levels in desirable pre- and Diabetes care: 1st level: prediction of the predisposition early in childhood. 2nd level: prediction of early/premature aging and prestages of Diabetes. 3rd level: prediction of Diabetes-related complications - cardiovascular, neurodegenerative and cancer diseases frequently developed in Diabetics. Predictive diagnosis is considered as the basis for targeted preventive measures and consequent creation of individualized treatment approaches. Communication among the professionals - healthcare providers, policy-makers, educators, etc., obligatory involved in the overall process to improving (pre)Diabetes care is of paramount importance.
Similar articles
-
Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine.EPMA J. 2010 Mar;1(1):3-12. doi: 10.1007/s13167-010-0014-5. Epub 2010 Mar 16. EPMA J. 2010. PMID: 23199036 Free PMC article.
-
["Other types" of diabetes: contra-insular hormones and genetic predisposition, new horizons of diagnostics and treatment].Vestn Ross Akad Med Nauk. 2012;(1):50-3. Vestn Ross Akad Med Nauk. 2012. PMID: 22550711 Russian.
-
Diabetes care: risk factors, prediction, prevention, and individualized treatment.Infect Disord Drug Targets. 2008 Jun;8(2):68-9. doi: 10.2174/187152608784746538. Infect Disord Drug Targets. 2008. PMID: 18537701
-
Epidemiologic perspectives of risk for developing diabetes and diabetes complications.Nurs Clin North Am. 2006 Dec;41(4):487-98, v. doi: 10.1016/j.cnur.2006.07.008. Nurs Clin North Am. 2006. PMID: 17059970 Review.
-
[Diabetes mellitus in children].Orv Hetil. 2005 Jun 19;146(25):1335-43. Orv Hetil. 2005. PMID: 16106756 Review. Hungarian.
Cited by
-
The potential role of angiopoietin-like protein-8 in type 2 diabetes mellitus: a possibility for predictive diagnosis and targeted preventive measures?EPMA J. 2019 Aug 6;10(3):239-248. doi: 10.1007/s13167-019-00180-3. eCollection 2019 Sep. EPMA J. 2019. PMID: 31462941 Free PMC article.
-
Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine.EPMA J. 2010 Mar;1(1):3-12. doi: 10.1007/s13167-010-0014-5. Epub 2010 Mar 16. EPMA J. 2010. PMID: 23199036 Free PMC article.
-
Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics.Infect Disord Drug Targets. 2012 Oct;12(5):332-9. doi: 10.2174/187152612804142215. Infect Disord Drug Targets. 2012. PMID: 23017160 Free PMC article.
-
Diabetes care in figures: current pitfalls and future scenario.EPMA J. 2018 May 22;9(2):125-131. doi: 10.1007/s13167-018-0133-y. eCollection 2018 Jun. EPMA J. 2018. PMID: 29896313 Free PMC article. Review.
-
Chromium-picolinate therapy in diabetes care: molecular and subcellular profiling revealed a necessity for individual outcome prediction, personalised treatment algorithms and new guidelines.Infect Disord Drug Targets. 2011 Apr;11(2):188-95. doi: 10.2174/187152611795589717. Infect Disord Drug Targets. 2011. PMID: 21470100 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
